------------------------
                                                             OMB APPROVAL
                                                        ------------------------
                          UNITED STATES                 OMB Number:    3235-0416
                SECURITIES AND EXCHANGE COMMISSION      Expires:  March 31, 2007
                      Washington, D.C. 20549            Estimated average burden
                                                        hours per response...182
                                                        ------------------------

                                   FORM 10-QSB
                                FILE NO. 0-29951


(Mark One)

|X|   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

      For the quarterly period ended March 31, 2002

|_|   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

      For the transition period from____________________to____________________
      Commission file number__________________________________________________


                               PEDIANET.COM, INC.
--------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)


            Georgia                                        58-1727874
--------------------------------------------------------------------------------
(State or other jurisdiction of                (IRS Employer Identification No.)
 incorporation or organization)

            830-13 A1A North, #165, Ponte Vedra Beach, Florida 32082
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (404) 583-0404
--------------------------------------------------------------------------------
                           (Issuer's telephone number)


--------------------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes |_| No |X|

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes |_|  No |_|

                APPLICABLE ONLYTO ISSUERS INVOLVED IN BANKRUPTCY
                     PROCEEDINGSDURINGTHEPRECEDINGFIVEYEARS

<PAGE>

Check whether the registrant filed all documents and reports required to be
filed by Section l2, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court. Yes |_| No |_|

                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

As of February 25, 2002, the company had issued and outstanding 12,225,133
shares of Common and Voting Preferred stock.

Transitional Small Business Disclosure Format (Check one): Yes |_| No |X|


SEC2334(9-05)         PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF
                      INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO
                      RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB
                      CONTROL NUMBER.


<PAGE>

                          PART I- FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

The company was not operational during the reporting period, nor for more that a
year prior to the reporting period. Although repeatedly requested from the
former Board, no financial or other records have been made available to the new
Board. Accordingly, current management is unable to provide a current financial
statement. Instead, the financial statement filed with the company's 10QSB on
May 21, 2001, for the period ending March 31, 2001, with adjustment for the
number of outstanding shares, is considered correct in the absence of facts to
the contrary, and that financial statement is, therefore, incorporated as a part
of this report.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

During the reporting period there were significant changes in management and in
the share structure of the company. See Item 5 of Part II , below, for a
description of the material events during the period.

ITEM 3. CONTROLS AND PROCEDURES.

Because of its operationally inactive status and the fact that management is the
only source of funds, the company's financial matters are simple, and financial
controls self-effecting, requiring only records that depict the company's
transactions, primarily consisting of minutes and actual proofs of payment.


                           PART II--OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

      None

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

      None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

      None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

      None


                                       3
<PAGE>

Item 5. Other Information

a.    On February 16, 2002, James E. Cheatham and C.M. Benedict were elected as
      Directors.

b.    On February 21, 2002, Harold Engel and Alan Cohen resigned as Directors,
      and Mr. Engel resigned as an officer. Both renounced all claims to
      compensation under any compensation agreement, as well as any claims for
      the acquisition of shares of the company; and, on February 21, 2002, the
      respective resignations of Mr. Engel and Mr. Cohen were accepted by the
      Board.

c.    On February 21, 2002, the Board adopted a Medical Reimbursement Plan,
      pursuant to Section 105 of the Internal Revenue Code.

d.    On February 21, 2002, the Board elected the following officers:

      James E. Cheatham, President; C. M. Benedict, Secretary; and, James E.
      Cheatham, Treasurer.

e.    On February 25, 2002, the Board approved a reverse split of one share for
      each three shares of the company's outstanding shares.

f.    On March 1, 2002, the company was authorized to issue its convertible
      promissory note in the principal sum of $30,000.00, with no interest until
      maturity, in favor of Incubadora del Futuro, S.L. in payment of accrued
      fees for services. The note matures March 3, 2005 and is convertible to
      common shares at the price of $0.012 per share.

g.    On March 4, 2002, the Board authorized the Secretary to notify the
      Secretary of State for Georgia that the company has abandoned the
      purported merger with drpaula.com, and notice was duly given.

h.    On March 6, 2002, the Board authorized the issuance to the company oficers
      of 5,000,000 shares each in consideration of services performed on behalf
      of the company. The monetary value of the shares was less than $10,000.00.

i.    On March 8, 2002, the board authorized the issuance of Warrants to the
      officers for the acquisition of 7,500,000 shares each over the next five
      years, at par value. The monetary value of the shares available under the
      Warrants was less than $10,000.00.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.

      None.


                                       4
<PAGE>

                                   SIGNATURES

      In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                                              PEDIANET.COM, INC.
                                              (Registrant)

Date: March 3, 2006

                                              By: /s/ C.M. Benedict
                                                  ------------------------------
                                                  C.M. Benedict, President


                                       5